GOVT-CONTRACT ·Filed Apr 1, 2026

MCK

MCKESSON CORP
BULLISH
Impact 7/10
Horizonmonths Processed4mo ago
Large government contract award ($500M+)
Actionable Insight ▲ Bullish

This contract adds over $1B in government revenue visibility for FY2026, reinforcing McKesson's stable government segment. Traders should watch for follow-on task orders and any margin commentary on the government distribution business in upcoming earnings calls.

DirectionBullish
Confidencehigh
Horizonmonths
Final — all horizons settled through T+60d
MCK ▲ +22.92% at T+60d
LONG call ✓ call won +22.92% · α vs SPY +21.95% · entry $733.09 → $901.12
Entry anchored
May 31, 2026
via day open
T+1d
+0.42%
call +0.42% · α +0.27%
$736.15
settled 4mo ago
T+5d
+5.81%
call +5.81% · α +8.56%
$775.66
settled 4mo ago
T+20d
+1.97%
call +1.97% · α +4.28%
$747.53
settled 3mo ago
T+60d
+22.92%
call +22.92% · α +21.95%
$901.12
settled 5w ago

Price Chart

Loading chart...

Executive Summary

McKesson Corporation was awarded a $1.19 billion contract by the Department of Veterans Affairs as the Pharmaceutical Prime Vendor for FY2026 April. This is a large, sole-source award that reinforces McKesson's dominant position as a government pharmaceutical distributor and provides significant revenue visibility.

Key Financial Metrics

Award Amount
$1.2B
Agency
Department of Veterans Affairs
Contract Type
new
Rev Impact
+0.7%

Key Facts

  • Award amount: $1,191,348,080.87
  • Awarding agency: Department of Veterans Affairs
  • Contract type: Pharmaceutical Prime Vendor (PPV) for FY2026 April
  • Start date: 2026-04-01
  • Recipient match verified: McKesson Corporation is the named recipient

Financial Impact

The $1.19B award represents approximately 0.7% of McKesson's annual revenue (based on FY2025 revenue of ~$170B), which is a notable but not transformative addition to a large revenue base.

revenuebacklog

Risk Factors

  • Government contracts are subject to funding availability and continuing resolutions
  • Government distribution margins are typically lower than commercial business
  • Execution risk on large-volume pharmaceutical distribution

Market Snapshot

Exchange
NYSE
Sector
Wholesale-Drugs, Proprietaries & Druggists' Sundries
Analyst Consensus
87% bullish (23 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
GOVT-CONTRACT Data (Synthetic)contract-36C24026K1007
15 reports for MCK
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for MCK — sortable, filterable
TypeNow
Aug 28, 2026
4w ago
8-K
NEUTRAL ★ 4/10
$885.32 $851.02▼ −3.87%▼ −3.93%$890.49 (+0.58%)
Jul 1, 2026
13w ago
8-K
NEUTRAL ★ 3/10
$768.06 $888.56▲ +15.69%▲ +17.87%$890.49 (+15.94%)
Jun 30, 2026
13w ago
DEFA14A
NEUTRAL ★ 2/10
$768.06 $888.56▲ +15.69%▲ +17.87%$890.49 (+15.94%)
Jun 12, 2026
15w ago
DEFA14A
NEUTRAL ★ 2/10
$779.78 $812.28▲ +4.17%▲ +4.92%$890.49 (+14.20%)
Jun 12, 2026
16w ago
8-K
NEUTRAL ★ 5/10
$784.05 $805.96▲ +2.79%▲ +1.01%$890.49 (+13.58%)
Jun 8, 2026
16w ago
Insider Cluster
NEUTRAL ★ 2/10
$766.64 $784.23▲ +2.29%▲ +0.66%$890.49 (+16.16%)
Jun 3, 2026
17w ago
Insider Cluster
NEUTRAL ★ 2/10
$739.40 $768.06▲ +3.88%▲ +5.00%$890.49 (+20.44%)
Jun 2, 2026
17w ago
Insider Cluster
NEUTRAL ★ 3/10
$736.15 $768.06▲ +4.34%▲ +6.15%$890.49 (+20.97%)
May 27, 2026
18w ago
Insider Cluster
NEUTRAL ★ 3/10
$756.13 $766.55▲ +1.38%▲ +3.67%$890.49 (+17.77%)
May 27, 2026
18w ago
Insider Cluster
NEUTRAL ★ 2/10
$756.13 $766.55▲ +1.38%▲ +3.67%$890.49 (+17.77%)
Showing 10 of 15

US Market Status

Market Open — Closes in 4h 35m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published May 31, 2026